Cheng et al. revealed that FSTL1 has elevated expression in breast cancer and activated integrin β3/Wnt signaling to enhance the stemness and reduce chemosensitivity of breast cancer cells [23]. This evidence concerns the gene FSTL1 and breast carcinoma.